CME to Extend Crypto Derivatives to 24/7 Trading, Adding AVAX and SUI Futures with Phased Launch in May CME Group has announced plans to make its regulated cryptocurrency futures and options available for 24/7 trading. It is currently finalizing the listing of Avalanche (AVAX) and Sui (SUI) futures for May 4, with full 24/7 trading for all crypto derivatives expected to begin on May 29. Both timelines are subject to regulatory approval. ([https://t.co/WckYEe274H](https://t.co/WckYEe274H)) According to the announcement, AVAX and SUI futures will be offered in both micro and standard contract sizes, designed to be accessible to institutional and retail traders alike. Giovanni Vicioso, Head of Crypto Products at CME, commented on the new contracts, stating they “provide more choices and greater capital efficiency,” with the expanded lineup aimed at strengthening CME’s ability to deliver liquidity within its regulated environment. ([https://t.co/WckYEe274H](https://t.co/WckYEe274H)) This move addresses the supply-demand gap historically created between spot markets—operating 24/7—and traditional listed derivatives, which previously lacked liquidity during weekends and off-hours. Compared to the always-on spot market, U.S. regulated markets have seen capital flow offshore or into perpetual contracts for position adjustments. Multiple media outlets note that CME’s initiative could help redirect such capital back into a more regulated environment. ([https://t.co/Ji5azbo6Xm](https://t.co/Ji5azbo6Xm)) Operationally, the transition to 24/7 trading includes weekly short maintenance windows and specific handling of trade and settlement dates—trades executed over the weekend will be treated as occurring on the next business day. These changes require brokers and clearing firms to update their systems to accommodate revised settlement and reporting timelines. Market participants must also monitor potential impacts on hedging strategies and the basis between futures and spot prices. ([https://t.co/KGN5AxMF3I](https://t.co/KGN5AxMF3I)) In summary, CME’s phased expansion enhances the accessibility of regulated markets and expands risk management tools for institutional investors. However, challenges remain, including the transition of real demand, potential liquidity fragmentation, and increased complexity in clearing operations. The official launch and implementation are contingent on regulatory progress, meaning the announced timelines may be subject to change based on future review outcomes. ([https://t.co/WckYEe274H](https://t.co/WckYEe274H))